Skip to content

Opus Pulse Generators Models 2001, 2003, and 2004

by Ela Medical, Inc.

510(k) K882474

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK882474 Date12 Sep 1988ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Models / Variants
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Opus Pulse Generators Models 2001, 2003, and 2004 are implantable pacemaker pulse-generators, designed to regulate cardiac rhythm by delivering electrical impulses to the heart. These devices are classified as Class III medical devices under FDA regulations, requiring pre-market approval due to their role in life-sustaining or life-supporting functions.

These pulse generators are intended for use in clinical settings by trained healthcare professionals, typically during surgical implantation procedures. Supplied sterile and intended for single-use implantation, they are regulated under FDA 510(k) clearance (K882474) and fall under the medical specialty of cardiovascular care. Each model is uniquely identified by its reference code and adheres to regulatory standards outlined in 21 CFR 870.3610.

Other devices from Ela Medical, Inc.

See all devices from Ela Medical, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are the Opus Pulse Generators Models 2001, 2003, and 2004 designed for reuse or single-use, and how does this affect their handling in the operating room?

    The Opus Pulse Generators Models 2001, 2003, and 2004 are supplied sterile and intended for single-use implantation only. This means they are not meant to be removed, cleaned, or reused after surgery. Clinicians must handle them as sterile, single-use devices to maintain patient safety and regulatory compliance, ensuring proper disposal after use.

  • What are the key differences between the Opus Pulse Generator Models 2001, 2003, and 2004 in terms of their regulatory and functional classification?

    While the Opus Pulse Generators Models 2001, 2003, and 2004 are all implantable pacemaker pulse-generators, they are each uniquely identified by their reference codes and collectively fall under FDA 510(k) clearance (K882474) as Class III devices. Their classification as substantially equivalent (SESE) under 21 CFR 870.3610 confirms they meet regulatory standards for life-sustaining cardiac rhythm regulation, but individual model specifications (e.g., battery life, programming features) are not detailed in the provided data.

  • How should these devices be stored before implantation, given their sterile and single-use nature?

    Since the Opus Pulse Generators are sterile and single-use, they must be stored in their original, unopened packaging in a clean, dry environment protected from contamination until immediately before use. The packaging ensures sterility is maintained, and any damaged or compromised packaging should be discarded to prevent infection risks during surgery.

  • What is the intended clinical setting and user for the Opus Pulse Generators, and why is this important?

    These devices are intended for use in clinical settings by trained healthcare professionals, specifically during surgical implantation procedures. Their classification as life-supporting (Class III) underscores the need for expertise in cardiovascular care, as improper handling or implantation could compromise patient safety. The FDA 510(k) clearance and advisory committee review (CV) further emphasize their specialized use in regulated medical environments.